Cipla Limited announced on May 13, 2026, that its board of directors has recommended a final dividend of ₹13 per equity share for FY26, with the record date set for June 5, 2026. The announcement was made alongside the outcome of the board meeting held on the same day, as disclosed to the National Stock Exchange.

Dividend Details

Year-on-Year Comparison

The FY26 dividend of ₹13 per share represents a decline of 18.75% compared to the ₹16 per share final dividend declared in FY25. This reversal breaks what had been a broadly upward trend in Cipla's payouts over recent years. In FY24, the company had declared ₹13 per share, matching the current year's figure, while FY23 saw a payout of ₹8.50 per share.

Dividend History and Trend Analysis

Cipla's dividend track record over the past decade shows a consistent growth trajectory, interrupted by the FY26 reduction. The per-share payouts have been as follows:

From ₹2 in FY17 to a peak of ₹16 in FY25, Cipla had multiplied its dividend eightfold over eight years. The step back to ₹13 in FY26 aligns with the FY24 level, suggesting the FY25 payout may have been an elevated year rather than a new baseline.

Market Context and Valuation

Cipla shares closed at ₹1,346.60 on May 13, 2026, up ₹54.30 or 4.20% on the day, suggesting the broader board meeting outcome was received positively by the market despite the lower dividend. The stock is currently trading at a price-to-earnings (PE) ratio of 22.97, modestly above the sector PE of 21.88, indicating a slight premium relative to the Nifty Pharma peer group.

In terms of the 52-week range, the stock touched a high of ₹1,673 on October 23, 2025, and a low of ₹1,165.70 on April 2, 2026. At the current price, Cipla is trading approximately 19.5% below its 52-week high and about 15.5% above its 52-week low, positioning it in the lower half of its annual range.

Delivery and Volume Data

Trading volumes on the announcement date stood at 32,50,719 shares, with a delivery percentage of 21.36%. This relatively low delivery ratio, against a sharp single-day price gain of over 4%, points toward a largely intraday-driven move rather than sustained institutional accumulation, a factor investors monitoring entry points may want to consider. The stock's daily volatility stands at 1.36%.

Company Overview

Cipla Limited, with a market capitalisation of ₹1,08,743.70 crore, is a constituent of the Nifty 50 and Nifty Pharma indices, among others. The Mumbai-headquartered company is one of India's largest pharmaceutical manufacturers, with a significant presence in chronic therapy segments and a growing US generics business. Eligible shareholders on record as of June 5, 2026, will qualify to receive the declared dividend upon formal shareholder approval at the upcoming annual general meeting.